Intellihealth Rebrands as FlyteHealth to Reflect Focus on Delivery of Cost-Effective Care for Obesity and Related Conditions

Comprehensive suite of clinical services, technology and support offers best-in-class care while controlling costs

NEW CANAAN, Conn., July 9, 2024 /PRNewswire/ — Intellihealth, a leader in supporting employers and patients in tech-enabled medical care for people with obesity and comorbid health conditions, announced today that it is rebranding as FlyteHealth for its customer and consumer-facing brand.

Intellihealth is rebranding as FlyteHealth for its customer and consumer-facing brand.

“As our business in the care and navigation of the best-in-class obesity medicine program continues to grow, employers, payers and patients have come to know us as Flyte. With that increased visibility, we are consolidating under FlyteHealth as a single brand,” said Sloan Saunders, FlyteHealth CEO. “This alignment allows us to continue to expand our offerings with our partners and provide a unified experience.”

Powered by the patent-pending Flyte Intelligence platform, FlyteHealth delivers a user-friendly experience through the FlyteHealth app, care by a team of obesity medicine experts, and patient navigation services.

The FlyteHealth approach is built upon the largest data set of obesity and chronic disease research available, as well as the decades of clinical experience of FlyteHealth’s founders — obesity medicine specialists who were among the first to see obesity not as a simple issue of willpower but as a complex disease that requires expert medical treatment.

FlyteHealth recently announced the multi-year expansion of a contract to provide its obesity medicine program to State of Connecticut health plan members and retirees.

For more information about FlyteHealth, please visit www.flytehealth.com.

About FlyteHealth
FlyteHealth delivers a comprehensive suite of clinical care, technology, and support. FlyteHealth reduces the complexity and cost of obesity and its comorbid conditions for employers and payers, and partners with healthcare professionals to offer care navigation services and subject matter expertise. Based on the founders’ decades of research and clinical care, its proven approach combines the latest in personalized medication therapy and behavior coaching to not only help people lose weight long-term, but also significantly improve related conditions such as diabetes, high blood pressure and heart disease. Built from the largest data set of obesity and chronic disease research, the Flyte Intelligence obesity treatment platform empowers clinicians to deliver the highest standard of patient care, consistently. For more information, please visit www.flytehealth.com.

FlyteHealth
Nicole Turgeon
nicole@intellihealthcorp.com
(206) 295-2060

View original content:https://www.prnewswire.com/news-releases/intellihealth-rebrands-as-flytehealth-to-reflect-focus-on-delivery-of-cost-effective-care-for-obesity-and-related-conditions-302191261.html

SOURCE FlyteHealth

Staff

Recent Posts

DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Ascension Health Customers Whose Data May Have Been Compromised

NEWTOWN, Pa., Dec. 22, 2024 /PRNewswire/ -- The law firm of Edelson Lechtzin LLP is…

34 minutes ago

Daily Fit Notes Rolls Out Affordable Fitness Solutions for the Modern Lifestyle

Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…

1 day ago

WillowWood Rebrand by DD.NYC Wins Gold Anthem Award for Product and Innovation in 2024 Rebrand

MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…

2 days ago

Quantum Biopharma Announces Closing of Second Tranche

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…

2 days ago

Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

2 days ago